SUN PHARMACEUTICAL INDUSTRIES INC recalls

16 recalls.

• Tretinoin Cream UPS recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIIReported October 14, 2026 · Failed Impurities/Degradation Specifications
• Tretinoin Cream USP recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIIReported October 14, 2026 · Failed Impurities/Degradation Specifications
• Tretinoin Cream USP recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIIReported October 14, 2026 · Failed Impurities/Degradation Specifications
• Carbamazepine Tablets recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIReported August 26, 2026 · CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
• Fexofenadine Hydrochloride Tablets recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIIReported July 8, 2026 · Failed Impurities/Degradation Specifications
• Perampanel CIII Tablets recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIReported July 1, 2026 · Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.
• Budesonide Inhalation Suspension recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIReported June 17, 2026 · Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the...
• DOXOrubin Hydrochloride Liposome injection recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IReported June 17, 2026 · Presence of Particulate matter: Particulate matter identified as glass.
• Xyvona recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIReported June 10, 2026 · Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona
• Xyvona recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIReported June 10, 2026 · Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona
• Fluocinonide recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIReported April 22, 2026 · Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
• Fluocinonide recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIReported April 22, 2026 · Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
• Fluocinonide recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIReported April 22, 2026 · Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
• Diclofenac Sodium recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIReported February 11, 2026 · Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
• Clindamycin Phosphate USP recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIIReported January 21, 2026 · Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
• Fluocinolone Acetonide Solution Topical Solution USP recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIIReported January 21, 2026 · Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D.